Autres langues Seikagaku Corporation

Actions

4548

JP3414000004

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
741 ^JPY	-0,40%		+0,54%	-2,63%

08/04	Ferring Pharmaceuticals Inc. Présente à l'ASIPP 2024 les données d'efficacité et d'innocuité de la phase 3 du traitement expérimental SI-6603 dans la hernie discale lombaire	CI
2023	Seikagaku Corporation publie ses résultats pour l'exercice clos le 31 mars 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Ferring Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603, in Lumbar Disc Herniation at ASIPP 2024	09/04
Seikagaku : Announces an Academic Conference Presentation on SI-6603 by Licensee Ferring Pharmaceuticals Inc.	09/04
Ferring Pharmaceuticals Inc. Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603, in Lumbar Disc Herniation at ASIPP 2024	08/04
Seikagaku : Financial Results for the Second Quarter of Fiscal Year 2023	10/11
Seikagaku : Consolidated Financial Results (Summary) for the First Three Months of Fiscal 2023 (Three-Month Period Ended June 30, 2023)	04/08/23
Seikagaku : Financial Results for the First Quarter of Fiscal Year 2023	04/08/23
Ferring Announces Positive Topline Phase 3 Results for SI-6603, an Investigational Treatment for Lumbar Disc Herniation	29/05/23
Seikagaku : Announces the Topline Results from a Phase III Clinical Study (Additional Study) in the U.S. for SI-6603, a Treatment for Lumbar Disc Herniation	26/05/23
Seikagaku : Convocation Notice of the 77th Ordinary General Meeting of Shareholders	22/05/23
Seikagaku : Convocation Notice of the 77th Ordinary General Meeting of Shareholders	19/05/23
Seikagaku : Consolidated Financial Results (Summary) for Fiscal 2022(Year Ended March 31, 2023)	12/05/23
Seikagaku Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	12/05/23
Seikagaku : Financial Results for the Fiscal Year 2022	12/05/23
Seikagaku : Consolidated Financial Results for the Thrid Quarter of Fiscal year 2022	08/02/23
Seikagaku : Financial Results for the Third Quarter of Fiscal Year 2022	08/02/23
Seikagaku : announces Results of Acquisition of Treasury Stocks and its Completion	28/12/22
Tranche Update on Seikagaku Corporation's Equity Buyback Plan announced on May 13, 2022.	26/12/22
Seikagaku Corporation's Equity Buyback announced on May 13, 2022, has closed with 1,725,700 shares, representing 3.10% for ¥1,499.99 million.	23/12/22
Seikagaku : announces the Progress of Acquisition of Treasury Stocks	01/12/22
Seikagaku : Financial Results for the Second Quarter of Fiscal Year 2022	18/11/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Seikagaku Corporation

Actions

4548

JP3414000004

Autres langues

Filtres